XML 14 R3.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2025
Sep. 30, 2024
Current Assets    
Cash and cash equivalents $ 21,160 $ 67,601
Prepaid expenses and other receivable 13,518 13,000
Right-of-use asset, net 0 4,773
Total Current Assets 34,678 85,374
TOTAL ASSETS 34,678 85,374
Current Liabilities    
Accrued interest 1,005 0
Other payable 0 6,414
Lease liability 0 5,038
Loan payable 297,134 1,811
Due to related party 22,154 139,523
Total Current Liabilities 320,293 152,786
Loan payable 94,886 99,387
Convertible notes payable 70,000 0
TOTAL LIABILITIES 485,179 252,173
CONTINGENCIES AND COMMITMENTS 0 0
Stockholders’ Deficit    
Common stock: 75,000,000 shares authorized; $0.001 par value 13,297,143 and 13,296,986 shares issued and outstanding at September 30, 2025 and 2024, respectively * [1] 13,297 13,297
Additional Paid-in Capital 7,769,284 7,769,284
Accumulated deficit (8,233,082) (7,949,380)
Total Stockholders’ Deficit (450,501) (166,799)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 34,678 $ 85,374
[1] retroactively reflect 1-for-5 reverse stock split effective on September 19, 2024